Home › Research › Disease mechanisms
Amygdala parcellation reveals unique subregions of atrophy in FTLD‐tauopathies
Jane K. Stocks, Rachel M. Keszycki, Daniel Gutstein, Todd Parrish, Rudolph J. Castellani, Changiz Geula, Elena Barbieri, Sandra Weıntraub et al.. Alzheimer s & Dementia, 2025-12-01
Topic: Brain proteins, microglia and lab models
Plain-language summary
PPA/3R had a mean age of 63.5 years (SD = 3.9), PPA/4R were 72.5 years (SD = 5.8), and controls were 63.4 years (SD = 6.8). In the left hemisphere, PPA/3R cases had smaller mean volumes than controls in the whole amygdala (p = 0.001) and all nuclei except the medial and paralaminar nuclei (i.e., lateral, basal, accessory basal, anterior amygdaloid area, cortical, central, and corticoamygdaloid transition area, all p <0.05). PPA/4R cases demonstrated smaller volumes than controls in only the paralaminar (p = 0.03) and corticoamygdaloid transition area (p = 0.009). Compared to PPA/4R, PPA/3R cases had reduced volumes in the whole amygdala (p = 0.04), lateral (p = 0.04), and cortical (p = 0.03) nuclei. There were no significant differences between disease groups in the right hemisphere. Results highlight the leftward asymmetry of disease in PPA and demonstrate increased atrophy of the amygdala in PPA/3R. Further, distinct portions of the amygdala were implicated in 3R versus 4R FTLD- tauopathy. Findings support prior research showing divergent neuropsychiatric phenotypes in FTLD-tauopathies, which may result from disruptions in amygdalar circuits governing emotional and behavioral processes. Future functional connectivity studies could offer greater insight into the pathways of limbic disruption in tauopathies.
What this study adds
Evidence grade: Low
This imaging study found that in primary progressive aphasia, cases with 3R tauopathy had more widespread left amygdala shrinkage than cases with 4R tauopathy. It maps patterns of atrophy only and does not test any treatment or prevention.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Stocks, J. K., Keszycki, R. M., Gutstein, D., Parrish, T., Castellani, R. J., Geula, C., et al. (2025). Amygdala parcellation reveals unique subregions of atrophy in FTLD‐tauopathies. Alzheimer s & Dementia. https://doi.org/10.1002/alz70856_100335
Vancouver
Stocks JK, Keszycki RM, Gutstein D, Parrish T, Castellani RJ, Geula C, et al. Amygdala parcellation reveals unique subregions of atrophy in FTLD‐tauopathies. Alzheimer s & Dementia. 2025. doi:10.1002/alz70856_100335. PMID: 41447155.
BibTeX
@article{stocks2025-41447155,
author = {Stocks, Jane K. and Keszycki, Rachel M. and Gutstein, Daniel and Parrish, Todd and Castellani, Rudolph J. and Geula, Changiz and Barbieri, Elena and Weıntraub, Sandra and others},
title = {{Amygdala parcellation reveals unique subregions of atrophy in FTLD‐tauopathies}},
journal = {Alzheimer s \& Dementia},
year = {2025},
doi = {10.1002/alz70856_100335},
pmid = {41447155},
url = {https://doi.org/10.1002/alz70856_100335}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- PPA/3R had a mean age of 63.5 years (SD = 3.9), PPA/4R were 72.5 years (SD = 5.8), and controls were 63.4 years (SD = 6.8).
- In the left hemisphere, PPA/3R cases had smaller mean volumes than controls in the whole amygdala (p = 0.001) and all nuclei except the medial and paralaminar nuclei (i.e., lateral, basal, accessory basal, anterior amygdaloid area, cortical, central, and corticoamygdaloid transition area, all p <0.05).
- PPA/4R cases demonstrated smaller volumes than controls in only the paralaminar (p = 0.03) and corticoamygdaloid transition area (p = 0.009).
- Compared to PPA/4R, PPA/3R cases had reduced volumes in the whole amygdala (p = 0.04), lateral (p = 0.04), and cortical (p = 0.03) nuclei.
- There were no significant differences between disease groups in the right hemisphere.
Why it matters
This imaging study found that in primary progressive aphasia, cases with 3R tauopathy had more widespread left amygdala shrinkage than cases with 4R tauopathy. It maps patterns of atrophy only and does not test any treatment or prevention.
Study details
- Evidence strengthLow
How this study scored 33/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer s & Dementia) |
| Journal's citation record | 2 / 4 | Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 0 / 7 | Cited 0 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.0 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 0 / 6 | Cited 0.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Tamar D. Gefen: h-index 25 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | Northwestern University: institution h-index 1,592 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41447155) |
| Free to read | 2 / 2 | Free to read |
| Total | 33 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1002/alz70856_100335
- PubMed: 41447155
- Original source →
- Free full text: Alzheimer s & Dementia →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Disease mechanisms from nearby years
Also tagged “phosphorylated”
732 studies in the library carry the topic tag “phosphorylated”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 732 tagged studies.